Internal Medicine, Nephrology · Rocky Mount, NC
NPI
1578730867
Since 2008
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
901 N Winstead Ave
Rocky Mount, NC, 27804
Phone (252) 937-0241
Groups this clinician bills Medicare through
Medicare paid, 2024
$163K
1,663 services
Medicare patients, 2024
432
Average age 72
Drug cost, 2024
$774K
2,231 prescriptions
Company payments, 2025
$15.41
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles S Jere was code 99232 (hospital e&m - subsequent), 413 times for 172 patients. In total Charles S Jere billed 1,663 services in 23 codes, and Medicare paid $163K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 413 | 172 | $58.40 | $24K |
| 99214 Office E&M - Established | Office | 222 | 132 | $84.66 | $19K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 208 | 127 | $11.66 | $2,426 |
| 99233 Hospital E&M - Subsequent | Facility | 147 | 41 | $86.09 | $13K |
| 90960 ESRD Related Services (not dialysis) | Office | 147 | 42 | $262.89 | $39K |
| 90961 ESRD Related Services (not dialysis) | Office | 107 | 36 | $218.70 | $23K |
| 99223 Hospital E&M - Initial | Facility | 103 | 94 | $128.73 | $13K |
| 90935 Hemodialysis | Facility | 96 | 50 | $52.47 | $5,037 |
| 90966 ESRD Related Services (not dialysis) | Office | 80 | 26 | $213.37 | $17K |
| 99222 Hospital E&M - Initial | Facility | 50 | 48 | $96.97 | $4,848 |
| 90970 ESRD Related Services (not dialysis) | Office | 30 | 12 | $7.03 | $211 |
| 36415 Venipuncture Blood Collection | Office | 18 | 14 | $8.65 | $156 |
| 99204 Office E&M - New | Office | 12 | 12 | $67.07 | $805 |
By year: 2022 $272K for 2,091 services; 2023 $169K for 1,521 services; 2024 $163K for 1,663 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 18 | 14 | $8.65 | $156 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles S Jere prescribed most often to Medicare patients was Sevelamer Carbonate, with 297 prescriptions and refills. In total Charles S Jere wrote 2,231 Medicare prescriptions that cost $774K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sevelamer Carbonate Generic | 297 | 328 | 69 | $64K |
| Amlodipine Besylate Generic | 137 | 310 | 43 | $762 |
| Velphoro Sucroferric Oxyhydroxide | 112 | 120 | 25 | $367K |
| Allopurinol Generic | 90 | 203 | 26 | $776 |
| Metoprolol Succinate Generic | 88 | 182 | 27 | $708 |
| Carvedilol Generic | 85 | 183 | 31 | $344 |
| Farxiga Dapagliflozin Propanediol | 77 | 85 | 14 | $46K |
| Furosemide Generic | 75 | 144 | 24 | $319 |
| Hydralazine Hcl Generic | 73 | 122 | 17 | $1,072 |
| Losartan Potassium Generic | 63 | 108 | 19 | $370 |
| Lokelma Sodium Zirconium Cyclosilicate | 59 | 60 | 17 | $29K |
| Veltassa Patiromer Calcium Sorbitex | 51 | 56 | 14 | $43K |
| Prednisone Generic | 51 | 59 | 14 | $150 |
| Clonidine Hcl Generic | 50 | 109 | 12 | $244 |
| Calcium Acetate Generic | 42 | 57 | 13 | $2,883 |
Brand drugs: - claims; generic drugs: 1,764 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles S Jere $15.41 ($15.41 in general payments such as food, travel and fees) from 2 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $13.75.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.